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Clostridial glucosylating cytotoxins inactivate mammalian Rho GTPases by mono-O glucosylation of a
conserved threonine residue located in the switch 1 region of the target protein. Here we report that EhRho1,
a RhoA-like GTPase from the protozoan parasite Entamoeba histolytica, is glucosylated by clostridial cytotoxins.
Recombinant glutathione S-transferase–EhRho1 and EhRho1 from cell lysate of Entamoeba histolytica were
glucosylated by Clostridium difficile toxin B and Clostridium novyi alpha-toxin. In contrast, Clostridium difficile
toxin A, which shares the same mammalian protein substrates with toxin B, did not modify EhRho1. Change
of threonine 52 of EhRho1 to alanine prevented glucosylation by toxin B from Clostridium difficile and by
alpha-toxin from Clostridium novyi, which suggests that the equivalent threonine residues are glucosylated in
mammalian and Entamoeba Rho GTPases. Lethal toxin from Clostridium sordellii did not glucosylate EhRho1
but labeled several other substrate proteins in lysates from Entamoeba histolytica in the presence of
UDP-[14C]glucose.
The Rho GTPases form a subgroup of the Ras superfamily
of low-molecular-mass GTP-binding proteins, which are ubiq-
uitously expressed and conserved across various eukaryotic
species, including yeast and humans. Prominent members of
this GTPase subfamily are Rho, Rac, and Cdc42, which func-
tion as molecular switches, cycling between an inactive GDP-
bound state and an active GTP-bound state (9, 31). The ratio
of the two forms is regulated by numerous guanine nucleotide
exchange factors (GEFs) and GTPase-activating proteins.
Guanine nucleotide dissociation inhibitors are another group
of regulatory proteins. Guanine nucleotide dissociation inhib-
itors extract Rho GTPases from membranes, keep them in the
cytosol, and block nucleotide exchange (27). In response to
extracellular stimuli, Rho proteins control a large array of
cellular processes, including organization of the cytoskeleton,
motility, cell polarity, endocytosis, gene transcription, regula-
tion of microtubule dynamics, and cell cycle progression (9).
Several bacterial protein toxins which target the cytoskele-
ton through modification of actin and low-molecular-mass
GTPases involved in regulation of the actin cytoskeleton have
been identified (2, 6). Besides their pathophysiological signif-
icance, these toxins are widely used as tools to study the mech-
anism of cellular pathways responsible for the maintenance
and stability of the cytoskeleton network. Cytotoxins from
Clostridium species inactivate Rho family GTPases by gluco-
sylation (7, 17, 19, 24). Members of this toxin family are Clos-
tridium difficile toxins A and B, Clostridium sordellii lethal and
hemorrhagic toxins, and Clostridium novyi alpha-toxin (30).
These toxins are single-chain proteins with molecular masses
of 250 to 308 kDa (17). C. difficile toxins A and B glucosylate
members of the Rho GTPase family (Rho, Rac, and Cdc42),
whereas C. sordellii lethal toxin glucosylates Rac and Ras sub-
family proteins (e.g., Ras, Ral, and Rap) but not RhoA (19,
20). C. novyi toxin, which shares the substrate specificity of
toxin B, is an O-GlcNAc transferase (26). These toxins modify
the highly conserved threonine 37 residue in RhoA (Thr35 of
Rac or Cdc42) located in the switch 1 region of these GTPases
(19). Mono-O glucosylation of this threonine residue has im-
portant functional consequences. First, it inhibits activation of
Rho proteins by GEFs. Second, glucosylation of Rho proteins
increases membrane binding. Third, it inhibits the interaction
of GTPases with their effectors (17, 25). Moreover, recent
studies indicate that glucosylation of Rho/Ras proteins blocks
the active conformation of the GTPases and stabilizes their
inactive forms (11, 28). Therefore, glucosylation of Rho
GTPases block Rho-dependent signaling pathways (6).
Entamoeba histolytica is a parasite which is the causative
agent of amoebiasis. Signal-induced rearrangement of the
actin cytoskeleton plays a crucial role in parasitic motility and
pathogenicity in terms of vesicle trafficking, contact-dependent
cell killing, and phagocytosis (4, 5, 29). Previously, several
low-molecular-mass GTPases, sharing significant sequence
similarity with mammalian Rho and Rac proteins, were iden-
tified in Entamoeba histolytica (15, 22, 23). The roles of Ent-
amoeba Rac orthologous EhRacA and EhRacG were estab-
lished in phagocytosis, uroid formation, cytokinesis, and
invasive behavior (10, 12, 15). EhPAK was identified as the
effector of EhRacG, which also efficiently interacted with hu-
man Rac1 (HsRac1) (21). Recently, an Entamoeba GEF
(EhGEF1) which stimulates the rate of nucleotide exchange
of EhRacG (20-fold) was identified (1). Functional studies
with EhRho proteins are limited in this organism. Recent study
shows that lysophosphatidic acid stimulation activated
EhRhoA1 and induced rearrangement in filamentous actin,
suggesting that Rho signaling modulates actomyosin-depen-
dent motility in this organism (10).
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We asked whether Rho GTPases from Entamoeba histolytica
are also substrates of bacterial protein toxins. Previous studies
demonstrate that EhRho1, the Rho-like GTPase from Ent-
amoeba histolytica, is not a substrate of the ADP-ribosylating
C3 exoenzyme of Clostridium botulinum (13). However, the
expression of C3 in Entamoeba histolytica showed an inhibition
of cytolytic activity and monolayer destruction (14). In the
present study, we used clostridial glucosylating cytotoxins to
modify the Rho proteins from Entamoeba histolytica. Our
study shows that EhRho1 is a preferred substrate for gluco-
sylation by Clostridium difficile toxin B and Clostridium novyi
alpha-toxin in vitro, although the holotoxins do not affect the
Entamoeba histolytica trophozoites in culture.
MATERIALS AND METHODS
Cell culture and maintenance. Entamoeba histolytica HM1:IMSS trophozoites
were maintained in TYIS 33 medium (22) at 37°C. Cells were routinely subcul-
tured for maintenance every 2 to 3 days, and trophozoites in the log phase of
growth (1 to 2 days) were used in all experiments. Clostridium difficile toxins A
and B (from strain VPI 10463) were prepared as described previously (18).
Clostridium sordellii lethal toxin (strain 6018) was purified as reported for toxin
B. Clostridium novyi alpha-toxin (strain type A 19402) was prepared as described
recently (26). The N-terminal enzymatic domain of toxin B, covering residues 1
to 546, was purified as described previously (16), and the N-terminal domain of
Clostridium novyi alpha-toxin (residues 1 to 551) was prepared as reported
previously (8) and used as a glutathione S-transferase (GST) fusion toxin.
Expression and purification of EhRho1. EhRho1 was picked from Entamoeba
genomic DNA (23), and the full-length coding DNA (636 bp) was subcloned in
pGEX-2TK. The recombinant plasmid was transformed in Escherichia coli
BL21(DE3), GST fusion protein production in bacterial culture was induced
with 250 M IPTG (isopropyl--D-thiogalactopyranoside) at an optical density
of 0.6, and the culture was incubated for a further 16 h at 25°C. Bacterial cells
from 1.5 liters of culture were collected by centrifugation (6,000  g at 4°C) and
sonicated in 30 ml lysis buffer (25 mM Tris-HCl [pH 7.4], 10 mM NaCl, 5 mM
MgCl2, 5 mM dithiothreitol, 1% Triton X-100, and 1 mM phenylmethylsulfonyl
fluoride). After centrifugation (23,500  g at 4°C), the lysate was incubated with
preequilibrated GST-Sepharose 4B beads (Amersham Bioscience, Freiburg,
Germany) for 1 h. Beads were washed with high-salt buffer (50 mM Tris-HCl [pH
8], 150 mM NaCl, and 5 mM MgCl2). GST-EhRho1 was eluted in a buffer
containing 50 mM Tris-HCl (pH 8), 5 mM MgCl2, and 5% glycerol in the
presence of 10 mM reduced glutathione for 30 min at 4°C. The purity of the
eluted protein was checked by 12.5% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) (Fig. 1).
Site-directed mutagenesis of EhRho1. A QuickChange kit (Stratagene,
Heidelberg, Germany) in combination with Pfu Turbo DNA polymerase was used
for the replacement of a single nucleotide in EhRho1–pGEX-2TK to prepare
EhRho1T52A–pGEX-2TK. The following oligonucleotides were used: EhRhoT52A
sense, CCG CTT ATG TCC CAG CAG TTT TTG AAA ATT TC; and
EhRhoT52A antisense, GAA ATT TTC AAA AAC TGC TGG GAC ATA AGC
GC. The corresponding plasmid was selected in E. coli XL1-Blue and the sequence
confirmed by automated sequencing. The mutated recombinant protein was purified
as described above for EhRho1.
Intrinsic GTPase assay. Equivalent amounts (1 M) of GST-EhRho1 and
GST-HsRhoA were loaded with [-32P]GTP for 5 min at 37°C in loading buffer
(50 mM Tris-HCl [pH 7.5], 10 mM EDTA, and 2 mM dithiothreitol). MgCl2
(final concentration, 12 mM) and unlabeled GTP (final concentration, 2 mM)
were added. GTP hydrolysis was carried out at 37°C. Proteins were collected by
filtration through wet 0.45-M nitrocellulose filter discs. The filters were washed
three times with ice-cold buffer A (50 mM Tris-HCl [pH 7.5], 50 mM NaCl, and
5 mM MgCl2), and protein-bound [-32P]GTP on the filters was quantified by
liquid scintillation counting.
Intrinsic GTP-binding assay. Equivalent amounts (1 M) of GST-EhRho1
and HsRhoA were loaded with [-32P]GTP (20 M final concentration) as
described above. After addition of unlabeled GTP (2 mM final concentration),
the intrinsic GTP release was carried out at 30°C, and the bound radioactivity
was measured by a filter binding assay as described above.
Preparation of cell lysate for in vitro glucosylation assay. A total of 3  105
Entamoeba histolytica trophozoites were harvested by chilling and then lysed in
100 l extraction buffer, containing 25 mM HEPES-KOH (pH 7.4), 50 mM KCl,
5 mM MgCl2, 2% glycerol supplemented with complete protease inhibitor
(Roche, Germany), 1 mM E-64 (Sigma, Germany), 1 mM phenylmethylsulfonyl
fluoride, and 0.5% Triton X-100. Thirty to 40 g of total cellular protein was
used in glucosylation reactions.
In vitro glucosylation assay. In vitro glucosylation was performed with the
holotoxins or with the N-terminal enzymatic domain of Clostridium difficile toxin
B (residues 1 to 546), Clostridium sordellii lethal toxin (residues 1 to 546), and
Clostridium novyi alpha-toxin (residues 1 to 551), which were purified as GST
fusion proteins. A total of 1 to 2 g purified GST-EhRho1 or GST-EhRho1T52A
was diluted in 20 l reaction buffer, containing 50 mM HEPES-KOH (pH 7.4),
FIG. 1. Amino acid sequence alignment of EhRho1 and HsRhoA. The amino acid sequence of EhRho1 (accession no. XP_652646) was aligned
with that of human RhoA (HsRhoA; accession no. AAM 21117) using ClustalW. The secondary structure of HsRhoA (PDB code 1ftn) was
included above the alignment using ESPript. The arrow below the EhRho1 sequence indicates the threonine residue which is the target for
glucosylation (Thr52 in EhRho1 is equivalent to Thr37 in HsRhoA).
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100 mM KCl, 2 mM MgCl2, 1 mM MnCl2, and 0.1 mg/ml bovine serum albumin,
and added with 10 M UDP-[14C]glucose or UDP-[14C]GlcNAc as required for
the corresponding enzyme. Reactions were started with the addition of recom-
binant toxins (final concentration, 7 to 10 ng/l). The reaction mixture was
incubated at 30°C for 30 min, stopped by SDS-PAGE sample buffer, and run on
SDS-PAGE followed by PhosphorImager analysis (Molecular Dynamics). The
labeled band intensity was measured by ImageQuant 5.2. Cold reactions were
carried out with unlabeled cosubstrate. Changes and modifications in the reac-
tion condition are mentioned in the figure legends.
Treatment of E. histolytica trophozoites with clostridial toxins. Entamoeba
histolytica trophozoites were grown on coverslips at 37°C in 24-well plates (2.4
ml). C. difficile toxin B or Clostridium novyi alpha-toxin was treated at various
concentrations ranging from 0.5 to 5 g/ml for 12 to 24 h at 37°C, and cells were
fixed with 3.7% formaldehyde–0.1% Triton X-100.
Staining for actin cytoskeleton and fluorescence microscopy. Formaldehyde-
fixed untreated and toxin-treated E. histolytica cells were extensively washed with
phosphate-buffered saline. Then the cells were incubated with rhodamine-con-
jugated phalloidin (1 U per coverslip) at room temperature for 1 h, washed again
with phosphate-buffered saline, and used for fluorescence microscopy (bleaching
preservative was Kaiser’s glycerol gelatin from Merck) under 40 oil objective
using an Axiocam camera (Carl Zeiss, Germany).
RESULTS
Purification of EhRho1 as a GST fusion recombinant pro-
tein. EhRho1 was identified as the closest homolog of eukary-
otic Rho proteins in Entamoeba histolytica (22). Compared to
the primary structure of HsRhoA, EhRho1 showed 48% iden-
tity, and predominant convergence of these two proteins lies in
the N-terminal region (alignment shown in Fig. 1). EhRho1
was expressed as a GST fusion protein in E. coli. The soluble
bacterial extract was affinity purified as described in Materials
and Methods. The eluted protein comigrated with the 45-kDa
molecular standard (Fig. 2A). Removal of the GST fusion
using thrombin was performed, but the resultant protein was
less stable. Hence, we used the stable GST-EhRho1 in most of
our studies.
GTPase activity of EhRho1 is comparable with that of
HsRhoA. To compare the biochemical properties of EhRho1
with human RhoA, we tested the intrinsic nucleotide binding
and GTP hydrolysis of purified EhRho1 and HsRhoA using a
filter binding assay as described in Materials and Methods.
GST-EhRho1 showed [-32P]GTP binding comparable to
that of HsRhoA. The GTPase activities of the two proteins,
which were measured by hydrolysis of [-32P]GTP, were
similar (Fig. 2B).
EhRho1 is a substrate for C. difficile toxin B and C. novyi
alpha-toxin but not for C. difficile toxin A. Clostridium difficile
releases two major toxins, toxin A and toxin B, which inactivate
the Rho family proteins (Rho, Rac, and Cdc42) by mono-O
glucosylation at the conserved Thr37. Purified EhRho1 was
subjected to glucosylation by these two toxins. GST-EhRho1
was a substrate for toxin B (Fig. 3), but toxin A was not able to
label the Entamoeba GTPase in the presence of UDP-[14C]glu-
cose, although toxin A could modify HsRhoA (Fig. 3). In
accordance with results obtained with recombinant EhRho1,
toxin B glucosylated EhRho1 in the cell lysate from Entamoeba
histolytica. Again toxin A could not label any protein in the cell
lysate (Fig. 3). Thus, toxin A and toxin B share protein sub-
strate specificity of mammalian Rho GTPases but not of Rho
GTPases from Entamoeba histolytica. Next, we studied the
glucosylation of EhRho1 by Clostridium novyi alpha-toxin,
which is an O-GlcNAc transferase but exhibits the same pro-
tein substrate specificity as toxin B in mammalian cells. For
these and the following in vitro studies, the recombinant
catalytic domains of the toxins were used. Alpha-toxin mod-
ified GST-EhRho1 (Fig. 4A) and also EhRho1 in cell lysate
(see Fig. 7B). The GlcNAc transferase from Clostridium
novyi modified the same amino acid residue as toxin B,
because the extent of radiolabeling decreased when EhRho1
was first preincubated with toxin B and then treated with
alpha-toxin (Fig. 4B).
EhRho1 is glucosylated at the conserved threonine residue.
Toxin B-induced depolymerization of actin filaments in mam-
malian cells is due to the mono-O glucosylation of RhoA at
Thr37 or Thr35 in Rac1 and Cdc42 (19). Also, Ras proteins,
which are targets of lethal toxin from Clostridium sordellii, are
modified at this conserved Thr35 residue, which is essential for
the functions of the GTPases. EhRho1 shows sequence con-
FIG. 2. Gel electrophoresis and biochemical activity of EhRho1.
(A) Bacterial cell lysate (CL) expressing GST-EhRho1 (arrow) was
loaded on glutathione-Sepharose matrix, and purified proteins were
eluted in the presence of 10 mM reduced glutathione. A 12.5% SDS-
PAGE was run and Coomassie-stained to check the purity of the
eluate (E). M, molecular mass marker. (B) Equivalent amounts (1 M
final concentration) of GST-EhRho1 (F) and GST-HsRhoA () were
loaded with [-32P]GTP, and the intrinsic GTPase activity was mea-
sured by a filter binding assay. The remaining bound radioactivity on
GST-EhRho1 and GST-HsRhoA is given as the percentage of the
maximum. Shown are data from experiments performed in triplicate
( standard error of the mean) (n 	 3).
7844 MAJUMDER ET AL. APPL. ENVIRON. MICROBIOL.
servation in the putative GTP-binding and effector binding
sites compared with the mammalian RhoA. According to the
sequence alignment shown in Fig. 1, Thr52 of EhRho1 was as-
sumed to be the conserved target for glucosylation. Hence, site-
directed mutagenesis was performed to construct EhRho1T52A.
Both toxin B and alpha-toxin did not modify GST-EhRho1T52A
(Fig. 5), suggesting that the covalent modification catalyzed by
these toxins occurred at the same amino acid as that known for
mammalian Rho protein substrates.
GDP-EhRho1 is the preferred substrate for glucosylation.
Previous studies have shown that RhoA when bound to GDP
is preferentially glucosylated compared to the GTP-bound
state (19). When recombinant EhRho1 was preloaded with
GDP, a higher incorporation of [14C]glucose was induced by
toxin B than with the GTP-bound form of GST-EhRho1, which
was poorly glucosylated (Fig. 6).
EhRho1 is a specific target of toxin B in the cell lysate of
Entamoeba histolytica. In higher eukaryotic organisms, toxin B
specifically blocks the function of RhoA/Rac1 proteins,
whereas lethal toxin from C. sordellii targets Rac and Ras
proteins but not RhoA. When the cellular lysate of Entamoeba
histolytica was treated with toxin B or alpha-toxin in the pres-
ence of 14C-labeled cosubstrates, only a single band, which was
most likely EhRho1, was detected (Fig. 7B). When the lysate
was pretreated with toxin B and unlabeled UDP-glucose, no
labeling with alpha-toxin could be detected in the presence of
14C-labeled cosubstrates (Fig. 7B). This result showed that
alpha-toxin and toxin B share the same substrate and acceptor
amino acid specificity towards the amoebic proteins. Lethal
FIG. 3. EhRho1 is glucosylated by Clostridium difficile toxin B but
not by Clostridium difficile toxin A. Affinity-purified GST-EhRho1 (1
g, lane 2) and total lysate from Entamoeba histolytica trophozoites (30
g of protein, lane 3) were incubated with toxin A (toxA) or toxin B
(toxB) (final concentrations, 7 ng/l of each of the holotoxins) in the
presence of 10 M UDP-[14C]glucose for 30 min at 30°C in a total
volume of 20 l. Purified HsRhoA (lane1) was used as the control for
glucosylation with each toxin. Radiolabeled proteins were analyzed by
SDS-PAGE and phosphorimaging.
FIG. 4. Clostridium novyi alpha-toxin modified EhRho1 similarly to
toxin B. (A) Purified GST-EhRho1 or HsRhoA (each 1 g) was incu-
bated with Clostridium difficile toxin B (toxB) or Clostridium novyi
alpha-toxin (-tox) (final concentrations, 7 ng/l of each of the cata-
lytic domains) in the presence of UDP-[14C] glucose (for toxin B) or
UDP-[14C]GlcNAc (for alpha-toxin) in a 20-l reaction volume. The
samples were subjected to SDS-PAGE followed by autoradiographic
analysis. (B) GST-EhRho1 (2 g) was preincubated with or without
Clostridium difficile toxin B and UDP-glucose (10 M) for 20 min at
30°C in a 20-l reaction volume. The preincubated samples were
subjected to a second modification by toxin B (toxB) and alpha-toxin
(-tox) (final concentrations, 10 ng/l each) with radiolabeled cosub-
strates for another 20 min at 30°C. Labeled proteins were analyzed by
SDS-PAGE and phosphorimaging. Pretreatment with toxin B or
alpha-toxin reduced subsequent second glucosylation, indicating the
same target sites.
FIG. 5. EhRho1 is glucosylated at the conserved threonine residue.
Purified GST-EhRho1 (lanes 1 and 3) and GST-EhRho1T52A (lanes
2 and 4) were used at the same concentration for glucosylation with
Clostridium difficile toxin B (toxB) or Clostridium novyi alpha-toxin
(-tox) (recombinant catalytic domains were used; final concentra-
tions, 10 ng/l each). Labeled proteins were analyzed by SDS-PAGE
(upper panel) and phosphorimaging analysis (lower panel). The dou-
ble band may indicate partial degradation of proteins. Shown is a
representative experiment repeated twice with similar results.
FIG. 6. GDP-EhRho1 is more efficiently modified by Clostridium
difficile toxin B than GTP-EhRho1. GST-EhRho1 was preloaded with
either GDP (}) or GTPS (Œ), and glucosylation reactions were
started with the addition of toxin B (final concentration, 10 ng/l of the
recombinant catalytic domain). At the indicated time points, labeled
proteins were analyzed by SDS-PAGE and phosphorimaging. Relative
band intensities were quantified with ImageQuant 5.2 and were plotted
as a function of time. Shown is a representative experiment performed
twice with similar results.
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toxin did not show any activity toward purified GST-EhRho1
(Fig. 7A, lane 2). However, when the cell lysate from Ent-
amoeba histolytica was treated with lethal toxin, several labeled
proteins with molecular masses of 20 to 30 kDa were detected
(Fig. 7B, protein bands a, c, and d). These results indicated the
presence of other Ras/Rac proteins, which were targets for
lethal toxin. Interestingly, the specificity of lethal toxin does
not overlap with the substrate specificity of toxin B or alpha-
toxin (Fig. 7B).
Toxin B and alpha-toxin could not intoxicate Entamoeba
histolytica trophozoites in culture. Rho GTPases are involved
in the organization of the actin cytoskeleton, and treatment of
cultured mammalian cells with the clostridial glucosylating cy-
totoxins induces a redistribution of actin filaments, leading to
morphological alterations and finally to rounding up of cells
(18). In contrast, microscopic studies of Entamoeba histolytica
trophozoites treated with toxin B or alpha-toxin did not show
such characteristic morphological changes, even at a compara-
bly high concentration (5 g/ml) of holotoxins (data not
shown). We could not detect any significant changes in the
morphology of actin structures of intoxicated cells compared to
untreated cells (data not shown). Moreover, when Entamoeba
histolytica trophozoites were treated with toxin B and alpha-
toxin at high concentrations (5 g/ml) and cell lysates were
prepared after 12 h, radiolabeling of proteins in the lysates was
not reduced compared to naı¨ve cells (data not shown). These
results suggest that the holotoxins are not able to enter Ent-
amoeba histolytica trophozoites in culture.
DISCUSSION
Rho family proteins play a crucial role in regulation of the
actin cytoskeleton network (9). By inhibiting the Rho signaling
cascade, clostridial glucosylating cytotoxins cause depolymer-
ization of the actin cytoskeleton of target cells (6). These toxins
monoglucosylate Rho proteins at a conserved threonine resi-
FIG. 7. Clostridium sordellii lethal toxin glucosylates other proteins from Entamoeba histolytica but not EhRho1. (A) Purified GST-EhRho1 (1
g) was used for glucosylation with Clostridium sordellii lethal toxin (lane 2). The modifications of GST-EhRho1 with Clostridium difficile toxin B
(lane 3) and HsRac1 (1 g) with Clostridium sordellii lethal toxin (lane 1) were performed as controls as described in Materials and Methods. Final
concentrations of the catalytic domains of the toxins were 7 ng/l. (B) Entamoeba histolytica trophozoite cell lysates were preincubated with either
Clostridium difficile toxin B (toxB) or Clostridium sordellii lethal toxin (LT) (concentrations of the catalytic domains of the toxins were 10 ng/l)
in the presence of unlabeled UDP-glucose for 20 min at 30°C. This was followed by a second incubation in the presence of radiolabeled
cosubstrates with toxin B (toxB), alpha-toxin (-tox), and lethal toxin (LT) for another 20 min under the same conditions. All samples were
separated by SDS-PAGE, and the bands were detected by phosphorimaging (a, b, c, and d indicate proteins labeled by the various toxins).
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due (Thr37 in Rho and Thr35 in Rac, Ras, or Cdc42), which is
located in the switch 1 region of the GTPases (17). The cova-
lent modification of Rho proteins prevents the active confor-
mation of the GTPase and results in uncoupling from its ef-
fectors and regulators.
Entamoeba histolytica, a human pathogen, is a unicellular
eukaryotic organism which represents a complex signaling net-
work. Although several Ras superfamily proteins, including the
RhoA-like GTPase EhRho1, have been identified in this or-
ganism, specific functions and the regulation of Rho proteins
are not well established (22, 23). EhRho1 shares high sequence
similarity with mammalian RhoA in its N-terminal region, sug-
gesting an important role in regulation of the actin cytoskele-
ton and in other Rho-dependent cellular functions of Ent-
amoeba histolytica (10). In the present study, we purified
recombinant EhRho1 and studied its intrinsic GTPase activity
in comparison with HsRhoA. The data obtained suggest that
EhRho1 has biochemical properties similar to those of mam-
malian RhoA. A major result of the present study is the finding
that the Entamoeba RhoA-like GTPase EhRho1 is gluco-
sylated by clostridial cytotoxins. Toxin B and alpha-toxin gluco-
sylated the recombinant protein expressed in E. coli as well as
the native EhRho1 in the cell lysate from Entamoeba histo-
lytica. Our studies suggest that toxin B and alpha-toxin act on
EhRho1 in a very similar manner as on mammalian RhoA.
EhRho1 was glucosylated in the switch 1 region at the same
conserved threonine residue as that known for mammalian
RhoA (note that Thr52 in EhRho1 is equivalent to Thr37 of
RhoA) (19). The toxin-catalyzed glucosylation of EhRho1 was
more efficient with the GDP-bound form than with the GTP
form of the GTPase. This finding suggests a very similar three-
dimensional structure of the switch 1 domains of EhRho1 and
HsRhoA. Thus, it is likely that the glucosylation of EhRho1
also affects the interaction of the GTPase with downstream
effector proteins. An interesting aspect of our work is the
finding that in contrast to toxin B, toxin A was not able to
glucosylate EhRho1. So far, it was suggested that toxin A and
toxin B target the same proteins (17), while our study indicates
a difference in substrate recognition by these two toxins. An-
other important finding was the labeling of additional proteins
by lethal toxin in Entamoeba histolytica cell lysate, whereas
EhRho1 was not modified. Deduced from the protein sub-
strate specificity of the toxins in mammalian cells, we can
expect a spectrum of Rho/Ras-like GTPases, which are specific
targets for these toxins.
Treatment of Entamoeba histolytica with the toxins did not
affect the behavior of the amoeba. We were also not able to
find evidence for a modification of Rho-like GTPases in the
intact protozoa. Therefore, we assume that the toxins are not
able to enter amoebae from outside the cells. So far, we do not
know whether the toxin receptors are missing or whether the
endocytic uptake machinery of Entamoeba histolytica does not
allow entry of the toxin. Recently, it was reported that C3
exoenzyme from Clostridium botulinum, which ADP ribo-
sylates mammalian Rho protein at Asn41 (3), is not able to
modify EhRho1 (13). In contrast, expression of C3 in intact
amoebae caused functional consequences, e.g., cell killing by
Entamoeba histolytica was inhibited (14). Therefore, it is im-
portant to study the functional consequences of the expression
of clostridial glucosylating cytotoxins in Entamoeba histolytica.
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